Rho-Kinase-IN-1

CAS No. 1035094-83-7

Rho-Kinase-IN-1( —— )

Catalog No. M26415 CAS No. 1035094-83-7

Rho-Kinase-IN-1 is a inhibitor of Rho kinase (ROCK) with Ki values of 30.5 and 3.9 nM for ROCK1 and ROCK2, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 260 Get Quote
10MG 410 Get Quote
25MG 678 Get Quote
50MG 954 Get Quote
100MG 1287 Get Quote
500MG 2574 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Rho-Kinase-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    Rho-Kinase-IN-1 is a inhibitor of Rho kinase (ROCK) with Ki values of 30.5 and 3.9 nM for ROCK1 and ROCK2, respectively.
  • Description
    Rho-Kinase-IN-1 is a inhibitor of Rho kinase (ROCK) with Ki values of 30.5 and 3.9 nM for ROCK1 and ROCK2, respectively.
  • In Vitro
    Rho-Kinase-IN-1 is a ROCK inhibitor which can be useful for treating diseases or conditions associated with excessive cell proliferation, remodeling, edema and inflammation.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    ROCK
  • Recptor
    Caspase| PAFR| PARP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1035094-83-7
  • Formula Weight
    352.5
  • Molecular Formula
    C20H24N4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (141.84 mM)
  • SMILES
    CSc1ccc(CN2CCCC(C2)Nc2ccc3[nH]ncc3c2)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wang JJ, Liu YX, et al. [Study on steroidal saponins from Dioscorea zingiberensis and their platelet aggregation activities]. Zhongguo Zhong Yao Za Zhi. 2014 Oct;39(19):3782-7. Chinese.
molnova catalog
related products
  • CAY10746

    CAY10746 is a selective Rho kinase (ROCK) inhibitor, targeting ROCK I and ROCK II with IC50 values of 0.014 μM and 0.003 μM, respectively.

  • Thiazovivin

    Thiazovivin (Tzv) is a novel ROCK inhibitor with IC50 of 0.5 μM, promotes hESC survival after single-cell dissociation.

  • Netarsudil mesylate

    Netarsudil mesylate (AR-13324 mesylate) is a Rho-related protein kinase inhibitor used to study glaucoma and hypertension.